MMP16 and schizophrenia: Because, risk variants of CNNM2, CSMD1, and MMP16 are suggested to be involved in one of symptoms of schizophrenia, cognitive impairment (Koiliari et al., 2014; Rose et al., 2014; Morton et al., 2017).